OPRM1 and Respiratory insufficiency due to muscle weakness: Finally, in agreement with the original paper, SR1701861 has been shown to produce minimal respiratory depression in comparison to other MOR agonists, albeit with a limited dosage window because of the use of a less-soluble salt version than the original SR17018 and using different methods to measure and quantify respiratory depression in mice63.